These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8722336)

  • 1. Allogeneic peripheral blood progenitor cell transplantation--the Australian experience.
    Szer J; Bardy P; Grigg A; Durrant S; Hutchins C; Herrmann R; Atkinson K
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S51-3. PubMed ID: 8722336
    [No Abstract]   [Full Text] [Related]  

  • 2. Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation.
    Negrin RS; Kusnierz-Glaz C; Blume KG; Strober S
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S31-3. PubMed ID: 8722331
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.
    Bensinger WI; Buckner CD; Rowley S; Demirer T; Storb R; Appelbaum FA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S38-9. PubMed ID: 8722333
    [No Abstract]   [Full Text] [Related]  

  • 4. Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia.
    Aversa F; Terenzi A; Tabilio A; Velardi A; Falzetti F; Felicini R; Carotti A; Ruggeri L; Reisner Y; Martelli MF
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S58-61. PubMed ID: 8722339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group].
    Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteyza J; Sierra J; García-Conde J; Rozman C
    Sangre (Barc); 1997 Apr; 42 Suppl 1():44-5. PubMed ID: 9381302
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
    Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Lambertenghi-Deliliers G; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S40-6. PubMed ID: 8722334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of allogeneic-peripheral blood stem cell transplantation and the possibility for unrelated donor-peripheral blood stem cell transplantation].
    Shinagawa K; Harada M
    Rinsho Ketsueki; 1998 May; 39(5):342-4. PubMed ID: 9637881
    [No Abstract]   [Full Text] [Related]  

  • 9. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
    Brunet S; Urbano-Ispizua A; Solano C; Ojeda E; Caballero D; Torrabadella M; de la Rubia J; Pérez-Oteiza J; Moraleda J; Espigado I; de la Serna J; Petit J; Bargay J; Mataix R; Vivancos P; Figuera A; Sierra J; Domingo-Albós A; Hernández F; García Conde J; Rozman C
    Sangre (Barc); 1997 Apr; 42 Suppl 1():42-3. PubMed ID: 9381301
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H
    Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results of allogeneic peripheral blood stem cell transplantation: Japanese survey 1995.
    Harada M; Kodera Y; Asano S
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S47-50. PubMed ID: 8722335
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
    Arat M; Arslan O; Ayyildiz E; Topcuoglu P; Dalva K; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.
    Azevedo WM; Aranha FJ; Gouvea JV; Vigorito AC; Marques JF; Eid KA; Azevedo AM; Barbosa KB; Souza CA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S54-5. PubMed ID: 8722337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.